 | Up a level |
Bagnoud, Maud; Remlinger, Jana; Joly, Sandrine; Massy, Marine; Salmen, Anke; Chan, Andrew; Karathanassis, Dimitris; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert (2024). Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis. CNS neuroscience & therapeutics, 30(2), e14484. Wiley 10.1111/cns.14484
Rebsamen, Michael; Friedli, Christoph; Radojewski, Piotr; Diem, Lara; Chan, Andrew; Wiest, Roland; Salmen, Anke; Rummel, Christian; Hoepner, Robert (2023). Multiple sclerosis as a model to investigate SARS‐CoV ‐2 effect on brain atrophy. CNS neuroscience & therapeutics, 29(2), pp. 538-543. Wiley 10.1111/cns.14050
Rusz, Jan; Krupička, Radim; Vítečková, Slávka; Tykalová, Tereza; Novotný, Michal; Novák, Jan; Dušek, Petr; Růžička, Evžen (2023). Speech and gait abnormalities in motor subtypes of de-novo Parkinson's disease. CNS neuroscience & therapeutics, 29(8), pp. 2101-2110. Wiley 10.1111/cns.14158
Hoepner, Robert; Kamm, Christian; Friedli, Christoph; Salmen, Anke; Chan, Andrew (2022). Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? CNS neuroscience & therapeutics, 28(6), pp. 971-973. Wiley 10.1111/cns.13841
Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes-Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert (2022). Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics, 28(12), pp. 1953-1963. Wiley 10.1111/cns.13938
Pistor, Maximilian; Hammer, Helly; Salmen, Anke; Hoepner, Robert; Friedli, Christoph (2022). Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort. CNS neuroscience & therapeutics, 28(5), pp. 792-795. Wiley 10.1111/cns.13806
Veselaj, Krenar; Kamber, Nicole; Briner, Myriam; Friedli, Christoph; Diem, Lara; Guse, Kirsten; Miclea, Andrei; Wiest, Roland; Wagner, Franca; Grabe, Hilary; Abegg, Mathias; Horn, Michael P.; Bigi, Sandra; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2021). Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics, 27(4), pp. 426-438. Wiley 10.1111/cns.13461
Miclea, A.; Salmen, Anke; Zoehner, G.; Diem, Lara; Kamm, Christian P.; Chaloulos-Iakovidis, Panagiotis; Miclea, M.; Briner, Myriam Sandra; Kilidireas, K.; Stefanis, L.; Chan, Andrew; Evangelopoulos, Maria Eleptheria; Hoepner, Robert (2019). Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. CNS neuroscience & therapeutics, 25(4), pp. 527-531. Blackwell Publishing 10.1111/cns.13083
Evangelopoulos, Maria Eleftheria; Miclea, Andrei; Schrewe, Lisa; Briner, Myriam; Salmen, Anke; Engelhardt, Britta; Huwiler, Andrea; Chan, Andrew; Hoepner, Robert (2018). Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod. CNS neuroscience & therapeutics, 24(10), pp. 984-986. Wiley 10.1111/cns.12992
Kinner, Markus; Hoepner, Robert; Klotz, Peter; Prehn, Christian; Faissner, Simon; Salmen, Anke; Linker, Ralf A; Gold, Ralf; Chan, Andrew (2016). Immunotherapy Improves Cognitive Function in Secondary Progressive Multiple Sclerosis. CNS neuroscience & therapeutics, 22(12), pp. 1019-1022. Wiley 10.1111/cns.12652
Sellner, Johann; Weber, Martin S; Vollmar, Patrick; Mattle, Heinrich P; Hemmer, Bernhard; Stüve, Olaf (2010). The Combination of Interferon-Beta and HMG-CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon? CNS neuroscience & therapeutics, 16(6), pp. 362-73. Oxford: Blackwell Publishing 10.1111/j.1755-5949.2010.00179.x
